![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: UBE2G2 |
Gene summary for UBE2G2 |
![]() |
Gene information | Species | Human | Gene symbol | UBE2G2 | Gene ID | 7327 |
Gene name | ubiquitin conjugating enzyme E2 G2 | |
Gene Alias | UBC7 | |
Cytomap | 21q22.3 | |
Gene Type | protein-coding | GO ID | GO:0000209 | UniProtAcc | P60604 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7327 | UBE2G2 | LZE4T | Human | Esophagus | ESCC | 7.95e-12 | 1.72e-01 | 0.0811 |
7327 | UBE2G2 | LZE7T | Human | Esophagus | ESCC | 2.30e-03 | 2.17e-01 | 0.0667 |
7327 | UBE2G2 | LZE8T | Human | Esophagus | ESCC | 6.52e-06 | 1.58e-01 | 0.067 |
7327 | UBE2G2 | LZE20T | Human | Esophagus | ESCC | 1.10e-06 | 1.44e-01 | 0.0662 |
7327 | UBE2G2 | LZE24T | Human | Esophagus | ESCC | 8.99e-20 | 5.17e-01 | 0.0596 |
7327 | UBE2G2 | P1T-E | Human | Esophagus | ESCC | 9.82e-07 | 4.53e-01 | 0.0875 |
7327 | UBE2G2 | P2T-E | Human | Esophagus | ESCC | 1.75e-30 | 6.47e-01 | 0.1177 |
7327 | UBE2G2 | P4T-E | Human | Esophagus | ESCC | 1.25e-31 | 8.41e-01 | 0.1323 |
7327 | UBE2G2 | P5T-E | Human | Esophagus | ESCC | 6.39e-14 | 4.55e-01 | 0.1327 |
7327 | UBE2G2 | P8T-E | Human | Esophagus | ESCC | 1.93e-12 | 1.72e-01 | 0.0889 |
7327 | UBE2G2 | P9T-E | Human | Esophagus | ESCC | 8.39e-12 | 3.62e-01 | 0.1131 |
7327 | UBE2G2 | P10T-E | Human | Esophagus | ESCC | 2.58e-48 | 9.27e-01 | 0.116 |
7327 | UBE2G2 | P11T-E | Human | Esophagus | ESCC | 8.79e-12 | 3.85e-01 | 0.1426 |
7327 | UBE2G2 | P12T-E | Human | Esophagus | ESCC | 1.65e-23 | 4.66e-01 | 0.1122 |
7327 | UBE2G2 | P15T-E | Human | Esophagus | ESCC | 1.54e-15 | 2.93e-01 | 0.1149 |
7327 | UBE2G2 | P16T-E | Human | Esophagus | ESCC | 2.34e-21 | 5.78e-01 | 0.1153 |
7327 | UBE2G2 | P17T-E | Human | Esophagus | ESCC | 4.28e-13 | 5.04e-01 | 0.1278 |
7327 | UBE2G2 | P19T-E | Human | Esophagus | ESCC | 1.40e-02 | 3.46e-01 | 0.1662 |
7327 | UBE2G2 | P20T-E | Human | Esophagus | ESCC | 1.79e-16 | 3.46e-01 | 0.1124 |
7327 | UBE2G2 | P21T-E | Human | Esophagus | ESCC | 1.32e-26 | 5.31e-01 | 0.1617 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:19049503 | Prostate | BPH | negative regulation of establishment of protein localization | 33/3107 | 131/18723 | 7.70e-03 | 3.39e-02 | 33 |
GO:00512242 | Prostate | BPH | negative regulation of protein transport | 32/3107 | 127/18723 | 8.56e-03 | 3.68e-02 | 32 |
GO:001049819 | Prostate | Tumor | proteasomal protein catabolic process | 158/3246 | 490/18723 | 3.05e-16 | 6.76e-14 | 158 |
GO:003497619 | Prostate | Tumor | response to endoplasmic reticulum stress | 97/3246 | 256/18723 | 2.92e-15 | 4.78e-13 | 97 |
GO:004316119 | Prostate | Tumor | proteasome-mediated ubiquitin-dependent protein catabolic process | 130/3246 | 412/18723 | 7.97e-13 | 8.00e-11 | 130 |
GO:003238614 | Prostate | Tumor | regulation of intracellular transport | 111/3246 | 337/18723 | 1.83e-12 | 1.65e-10 | 111 |
GO:003315717 | Prostate | Tumor | regulation of intracellular protein transport | 81/3246 | 229/18723 | 3.47e-11 | 2.37e-09 | 81 |
GO:007093615 | Prostate | Tumor | protein K48-linked ubiquitination | 26/3246 | 65/18723 | 1.33e-05 | 1.83e-04 | 26 |
GO:003043312 | Prostate | Tumor | ubiquitin-dependent ERAD pathway | 30/3246 | 85/18723 | 5.26e-05 | 5.75e-04 | 30 |
GO:005105112 | Prostate | Tumor | negative regulation of transport | 114/3246 | 470/18723 | 7.43e-05 | 7.82e-04 | 114 |
GO:003650313 | Prostate | Tumor | ERAD pathway | 35/3246 | 107/18723 | 8.02e-05 | 8.19e-04 | 35 |
GO:000020914 | Prostate | Tumor | protein polyubiquitination | 64/3246 | 236/18723 | 1.08e-04 | 1.03e-03 | 64 |
GO:003097012 | Prostate | Tumor | retrograde protein transport, ER to cytosol | 14/3246 | 29/18723 | 1.22e-04 | 1.14e-03 | 14 |
GO:190351312 | Prostate | Tumor | endoplasmic reticulum to cytosol transport | 14/3246 | 29/18723 | 1.22e-04 | 1.14e-03 | 14 |
GO:003252712 | Prostate | Tumor | protein exit from endoplasmic reticulum | 19/3246 | 48/18723 | 2.23e-04 | 1.90e-03 | 19 |
GO:190382812 | Prostate | Tumor | negative regulation of cellular protein localization | 36/3246 | 117/18723 | 2.55e-04 | 2.14e-03 | 36 |
GO:007086111 | Prostate | Tumor | regulation of protein exit from endoplasmic reticulum | 12/3246 | 27/18723 | 9.52e-04 | 6.20e-03 | 12 |
GO:00708622 | Prostate | Tumor | negative regulation of protein exit from endoplasmic reticulum | 6/3246 | 10/18723 | 3.00e-03 | 1.61e-02 | 6 |
GO:003238711 | Prostate | Tumor | negative regulation of intracellular transport | 19/3246 | 58/18723 | 3.18e-03 | 1.66e-02 | 19 |
GO:190495011 | Prostate | Tumor | negative regulation of establishment of protein localization | 35/3246 | 131/18723 | 4.63e-03 | 2.28e-02 | 35 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04141211 | Esophagus | ESCC | Protein processing in endoplasmic reticulum | 147/4205 | 174/8465 | 3.29e-22 | 1.10e-19 | 5.64e-20 | 147 |
hsa0412027 | Esophagus | ESCC | Ubiquitin mediated proteolysis | 122/4205 | 142/8465 | 6.53e-20 | 7.29e-18 | 3.74e-18 | 122 |
hsa05012211 | Esophagus | ESCC | Parkinson disease | 201/4205 | 266/8465 | 1.56e-18 | 8.72e-17 | 4.46e-17 | 201 |
hsa05022210 | Esophagus | ESCC | Pathways of neurodegeneration - multiple diseases | 318/4205 | 476/8465 | 6.10e-15 | 2.04e-13 | 1.05e-13 | 318 |
hsa04141310 | Esophagus | ESCC | Protein processing in endoplasmic reticulum | 147/4205 | 174/8465 | 3.29e-22 | 1.10e-19 | 5.64e-20 | 147 |
hsa0412036 | Esophagus | ESCC | Ubiquitin mediated proteolysis | 122/4205 | 142/8465 | 6.53e-20 | 7.29e-18 | 3.74e-18 | 122 |
hsa05012310 | Esophagus | ESCC | Parkinson disease | 201/4205 | 266/8465 | 1.56e-18 | 8.72e-17 | 4.46e-17 | 201 |
hsa0502238 | Esophagus | ESCC | Pathways of neurodegeneration - multiple diseases | 318/4205 | 476/8465 | 6.10e-15 | 2.04e-13 | 1.05e-13 | 318 |
hsa0412021 | Liver | Cirrhotic | Ubiquitin mediated proteolysis | 72/2530 | 142/8465 | 1.32e-07 | 1.97e-06 | 1.21e-06 | 72 |
hsa0412031 | Liver | Cirrhotic | Ubiquitin mediated proteolysis | 72/2530 | 142/8465 | 1.32e-07 | 1.97e-06 | 1.21e-06 | 72 |
hsa0414122 | Liver | HCC | Protein processing in endoplasmic reticulum | 146/4020 | 174/8465 | 7.34e-24 | 2.46e-21 | 1.37e-21 | 146 |
hsa0501222 | Liver | HCC | Parkinson disease | 198/4020 | 266/8465 | 9.40e-20 | 1.58e-17 | 8.76e-18 | 198 |
hsa0412041 | Liver | HCC | Ubiquitin mediated proteolysis | 110/4020 | 142/8465 | 1.67e-13 | 3.74e-12 | 2.08e-12 | 110 |
hsa0502222 | Liver | HCC | Pathways of neurodegeneration - multiple diseases | 298/4020 | 476/8465 | 6.59e-12 | 1.30e-10 | 7.22e-11 | 298 |
hsa0414132 | Liver | HCC | Protein processing in endoplasmic reticulum | 146/4020 | 174/8465 | 7.34e-24 | 2.46e-21 | 1.37e-21 | 146 |
hsa0501232 | Liver | HCC | Parkinson disease | 198/4020 | 266/8465 | 9.40e-20 | 1.58e-17 | 8.76e-18 | 198 |
hsa0412051 | Liver | HCC | Ubiquitin mediated proteolysis | 110/4020 | 142/8465 | 1.67e-13 | 3.74e-12 | 2.08e-12 | 110 |
hsa0502232 | Liver | HCC | Pathways of neurodegeneration - multiple diseases | 298/4020 | 476/8465 | 6.59e-12 | 1.30e-10 | 7.22e-11 | 298 |
hsa0414130 | Oral cavity | OSCC | Protein processing in endoplasmic reticulum | 143/3704 | 174/8465 | 6.82e-26 | 2.28e-23 | 1.16e-23 | 143 |
hsa0501230 | Oral cavity | OSCC | Parkinson disease | 188/3704 | 266/8465 | 1.82e-19 | 1.52e-17 | 7.75e-18 | 188 |
Page: 1 2 3 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
UBE2G2 | SNV | Missense_Mutation | novel | c.235N>T | p.His79Tyr | p.H79Y | P60604 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-D8-A73U-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | SD |
UBE2G2 | SNV | Missense_Mutation | rs782636745 | c.434N>A | p.Arg145His | p.R145H | P60604 | protein_coding | deleterious(0) | probably_damaging(0.98) | TCGA-EA-A410-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
UBE2G2 | SNV | Missense_Mutation | rs782079899 | c.62N>T | p.Pro21Leu | p.P21L | P60604 | protein_coding | tolerated(0.3) | possibly_damaging(0.742) | TCGA-D5-6530-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
UBE2G2 | SNV | Missense_Mutation | c.236N>G | p.His79Arg | p.H79R | P60604 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-G4-6322-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | oxaliplatin | PD | |
UBE2G2 | SNV | Missense_Mutation | novel | c.412G>A | p.Val138Met | p.V138M | P60604 | protein_coding | deleterious(0) | probably_damaging(0.945) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
UBE2G2 | SNV | Missense_Mutation | novel | c.260N>T | p.Arg87Ile | p.R87I | P60604 | protein_coding | deleterious(0.04) | benign(0.136) | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
UBE2G2 | SNV | Missense_Mutation | novel | c.436N>A | p.Asp146Asn | p.D146N | P60604 | protein_coding | tolerated(0.13) | benign(0.003) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
UBE2G2 | SNV | Missense_Mutation | novel | c.128N>A | p.Gly43Asp | p.G43D | P60604 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
UBE2G2 | SNV | Missense_Mutation | novel | c.365N>G | p.Ser122Trp | p.S122W | P60604 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-BG-A3EW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
UBE2G2 | SNV | Missense_Mutation | novel | c.494N>C | p.Leu165Pro | p.L165P | P60604 | protein_coding | deleterious(0) | probably_damaging(0.939) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |